Clinical trial

Dose-finding Study of GLPG0634 as add-on to Methotrexate in Active Rheumatoid Arthritis Participants (DARWIN1)

NCT01888874

Drugs and interventions used in this trial

2 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

DRUG · Unmapped registry intervention GLPG0634 Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention Placebo Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

Dose-finding Study of GLPG0634 as add-on to Methotrexate in Active Rheumatoid Arthritis Participants (DARWIN1)

Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE2

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2013-07-17

PhasePHASE2

Conditions

Rheumatoid Arthritisverified · MONDO: rheumatoid arthritis

Interventions

GLPG0634DRUG

PlaceboDRUG

Sponsors & collaborators

Lakefront Biotherapeutics NVlead sponsor

Mapped research locations

SofiaBulgaria4 MoscowRussia3 BudapestHungary3 KrakowPoland3 KharkivUkraine3 SantiagoChile3 BogotáColombia3 BerlinGermany2 BrusselsBelgium2 Buenos AiresArgentina2 HaifaIsrael2 MonterreyMexico2

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01888874 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.